P3 Health Partners (NASDAQ:PIII – Get Free Report) is one of 33 public companies in the “Health services” industry, but how does it compare to its competitors? We will compare P3 Health Partners to related companies based on the strength of its analyst recommendations, dividends, institutional ownership, valuation, risk, profitability and earnings.
Profitability
This table compares P3 Health Partners and its competitors’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| P3 Health Partners | -10.92% | -2,471.27% | 33.63% |
| P3 Health Partners Competitors | -145.90% | -203.90% | -19.43% |
Institutional & Insider Ownership
21.9% of P3 Health Partners shares are owned by institutional investors. Comparatively, 45.9% of shares of all “Health services” companies are owned by institutional investors. 17.1% of P3 Health Partners shares are owned by insiders. Comparatively, 24.7% of shares of all “Health services” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Valuation and Earnings
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| P3 Health Partners | $1.05 billion | -$270.13 million | 0.00 |
| P3 Health Partners Competitors | $1.61 billion | -$101.11 million | 20.82 |
P3 Health Partners’ competitors have higher revenue and earnings than P3 Health Partners. P3 Health Partners is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Analyst Recommendations
This is a breakdown of current recommendations and price targets for P3 Health Partners and its competitors, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| P3 Health Partners | 0 | 1 | 0 | 0 | 2.00 |
| P3 Health Partners Competitors | 10 | 163 | 311 | 0 | 2.62 |
As a group, “Health services” companies have a potential upside of 2,511.05%. Given P3 Health Partners’ competitors stronger consensus rating and higher possible upside, analysts clearly believe P3 Health Partners has less favorable growth aspects than its competitors.
Volatility & Risk
P3 Health Partners has a beta of 1.23, meaning that its stock price is 23% more volatile than the S&P 500. Comparatively, P3 Health Partners’ competitors have a beta of 1.49, meaning that their average stock price is 49% more volatile than the S&P 500.
Summary
P3 Health Partners competitors beat P3 Health Partners on 10 of the 12 factors compared.
P3 Health Partners Company Profile
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.
Receive News & Ratings for P3 Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for P3 Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.
